메뉴 건너뛰기




Volumn 96, Issue 10, 2000, Pages 3544-3552

Therapeutic efficacy of FcγRI/CD64-directed bispecific antibodies in B-cell lymphoma

Author keywords

[No Author keywords available]

Indexed keywords

CD19 ANTIGEN; CD64 ANTIGEN; GRANULOCYTE COLONY STIMULATING FACTOR; IMMUNOGLOBULIN F(AB')2 FRAGMENT; IMMUNOGLOBULIN FC FRAGMENT; LYMPHOCYTE ANTIGEN RECEPTOR; MAJOR HISTOCOMPATIBILITY ANTIGEN CLASS 2; MONOCLONAL ANTIBODY; BISPECIFIC ANTIBODY; FC RECEPTOR; IMMUNOGLOBULIN G;

EID: 0034668385     PISSN: 00064971     EISSN: None     Source Type: Journal    
DOI: 10.1182/blood.v96.10.3544.h8003544_3544_3552     Document Type: Article
Times cited : (62)

References (47)
  • 3
    • 0032850677 scopus 로고    scopus 로고
    • Multinational study of the efficacy and safety of humanized anti-HER2 monoclonal antibody in women who have HER2-overexpressing metastatic breast cancer that has progressed after chemotherapy for metastatic disease
    • (1999) J Clin Oncol , vol.17 , pp. 2639-2648
    • Cobleigh, M.A.1    Vogel, C.L.2    Tripathy, D.3
  • 5
    • 0028127935 scopus 로고
    • Lymphoma regression induced by monoclonal anti-idiotypic antibodies correlates with their ability to induce Ig signal transduction and is not prevented by tumor expression of high levels of Bcl-2 protein
    • (1994) Blood , vol.83 , pp. 906
    • Vuist, W.M.J.1    Levy, R.2    Maloney, D.G.3
  • 7
    • 0032530929 scopus 로고    scopus 로고
    • Monoclonal antibody therapy of B cell lymphoma: Signaling activity on tumor cells appears more important than recruitment of effectors
    • (1998) J Immunol , vol.161 , pp. 3176-3185
    • Tutt, A.L.1    French, R.R.2    Illidge, T.M.3
  • 13
    • 0031053094 scopus 로고    scopus 로고
    • Preclinical studies with FcγR bispecific antibodies and G-CSF primed neutrophils as effector cells against HER-2/neu overesxpressing breast cancer
    • (1997) Cancer Res , vol.57 , pp. 696-701
    • Stockmeyer, B.1    Valerius, T.2    Repp, R.3
  • 25
    • 0025602264 scopus 로고
    • The induction of skingraft tolerance in MHC-mismatched or primed recipients: Primed T-cells can be tolerized in the periphery with CD4 and CD8 antibodies
    • (1990) Eur J Immunol , vol.20 , pp. 2747-2755
    • Cobbold, S.P.1    Martin, G.2    Waldmann, H.3
  • 26
    • 0000097822 scopus 로고
    • 3 antibody derivatives
    • Gallagher G, Rees RC, Reynolds CW, eds. Tumor Immunobiology, a Practical Approach. Oxford: Oxford University Press
    • (1993) , pp. 225-244
    • Glennie, M.J.1    Tutt, A.L.2    Greenman, J.3
  • 28
    • 0026000790 scopus 로고
    • Neutrophils express the high affinity receptor for IgG (FcγRI; CD64) after in vivo application of rhG-CSF
    • (1991) Blood , vol.78 , pp. 885-889
    • Repp, R.1    Valerius, T.2    Sendler, A.3
  • 29
    • 0015963487 scopus 로고
    • Editorial: Guidelines On the analysis of tumor rates and death rates in experimental animals
    • (1974) Br J Cancer , vol.29 , pp. 101-105
    • Peto, R.1
  • 31
    • 0345365618 scopus 로고    scopus 로고
    • HLA class II as potential target antigen on malignant B cells for therapy with bispecific antibodies in combination with granulocyte colony-stimulating factor
    • (1996) Blood , vol.87 , pp. 3803-3812
    • Elsasser, D.1    Valerius, T.2    Repp, R.3
  • 36
    • 0030735798 scopus 로고    scopus 로고
    • Idiotype vaccines for non-Hodgkin's lymphoma induce polyclonal immune responses that cover mutated tumor idiotypes: Comparison of different vaccine formulation
    • (1997) Blood , vol.90 , pp. 3699-3706
    • Caspar, C.B.1    Levy, S.2    Levy, R.3
  • 43
    • 0033564979 scopus 로고    scopus 로고
    • The FcγRIA (CD64) ligand binding chain triggers major histocompatability complex class II antigen presentation independently of its associated FcR γ-chain
    • (1999) Blood , vol.94 , pp. 808-817
    • Van Vugt, M.1    Kleijmeer, M.J.2    Keler, T.3


* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.